Laboratorios Farmaceuticos Rovi S.A · LABFF.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $955.33M − (Liabilities $276.69M + Equity $664.17M) = $14.48M · out of balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$97.94M
10.3%
$70.75M
260.3%
Assets
Receivables
$177.50M
18.6%
$33.39M
23.2%
Assets
Inventory
$287.87M
30.1%
-$42.09M
-12.8%
Assets
PPE
$330.61M
34.6%
$43.99M
15.3%
Assets
Goodwill & intangibles
$35.87M
3.8%
$1.92M
5.7%
Assets
Other
$25.54M
2.7%
$15.35M
150.5%
Liabilities + Equity
Accounts payable
$68.21M
7.2%
-$18.64M
-21.5%
Liabilities + Equity
Short-term debt
$28.52M
3.0%
$4.83M
20.4%
Liabilities + Equity
Long-term debt
$83.88M
8.9%
$3.37M
4.2%
Liabilities + Equity
Other liabilities
$96.09M
10.2%
$36.65M
61.7%
Liabilities + Equity
Equity
$664.17M
70.6%
$92.14M
16.1%